tiprankstipranks
Trending News
More News >
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market

Regen Biopharma (RGBP) Financial Statements

Compare
123 Followers

Regen Biopharma Financial Overview

Regen Biopharma's market cap is currently $103.58K. The company's EPS TTM is $-0.088; its P/E ratio is -0.19; Regen Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total Revenue$ 236.56K$ 236.56K$ 236.56K$ 235.52K$ 171.19K
Gross Profit$ 236.56K$ 236.56K$ 236.56K$ 185.52K$ 146.19K
Operating Income$ -338.54K$ -417.00K$ -687.00K$ -340.00K$ -201.00K
EBITDA$ -338.54K$ -418.00K$ 3.12M$ 2.99M$ -6.20M
Net Income$ -1.27M$ -668.00K$ 1.02M$ 2.23M$ -6.76M
Balance Sheet
Cash & Short-Term Investments$ 716.00$ 716.00$ 121.04K$ 51.20K$ 727.16K
Total Assets$ 274.63K$ 177.61K$ 353.62K$ 559.00K$ 1.21M
Total Debt$ 793.70K$ 814.70K$ 756.20K$ 1.27M$ 3.58M
Net Debt$ 792.98K$ 813.98K$ 635.17K$ 1.22M$ 2.86M
Total Liabilities$ 6.56M$ 5.37M$ 5.46M$ 8.60M$ 14.70M
Stockholders' Equity$ -6.28M$ -5.19M$ -5.10M$ -8.04M$ -13.49M
Cash Flow
Free Cash Flow$ -383.59K$ -693.14K$ -173.92K$ -606.92K$ -1.13M
Operating Cash Flow$ -383.59K$ -693.14K$ -173.92K$ -606.92K$ -1.13M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 25.00K$ 495.00K
Financing Cash Flow$ 452.43K$ 572.82K$ 243.75K$ -94.04K$ 1.36M
Currency in USD

Regen Biopharma Earnings and Revenue History

Regen Biopharma Debt to Assets

Regen Biopharma Cash Flow

Regen Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.